Clinical Practice Issues

1071

Indications for Antibiotic Orders: How Accurate Are They?
Emily Heil, PharmD, BCPS-AQID; Lisa Pineles, MA; Daniel Morgan, MD, MS, FIDSA, FSHEA; Anthony D. Harris, MD, MPH; Kerri Thom, MD, MS

Posters

Abx Indications Poster_ID Week_corrected.pdf (88.6 kB)

1072

Fixed Versus Free-Text Documentation Of Indication For Antibiotic Orders
Waleed Javaid, MD; Shaelyn Cavanaugh, MPH; Christina Lupone, MPH; Telisa Stewart, DrPH; Tasaduq Fazili, MBBS; Benjamin White, MD

Posters

ID Week Poster - FInal2.pdf (1.4 MB)

1073

Antibiotic prescription patterns for acute diarrhea in a hospital in Shanghai in 2016: a cross-sectional study
Yanhong Hu, PhD M.D; Shanjuan Wang, M.D; Sunying Hua, M.D; Merlin Willcox, DPhil; Michael Moore, BM, BS, MRCP, FRCGP; Paul Little, MBBS, BA, MD, DLSHTM, MRCP, FRCGP, FMedSci

Posters

Presentation-Shanghai hospital data.pdf (423.3 kB)

1074

Causal Conditions Supporting Antibiotic Stewardship Information Dashboards
Jacob Kean, PhD; Jorie Butler, PhD; Lisa Bunker, MA; Matthew Goetz, MD; Peter Glassman, MBBS, MSc; Makoto Jones, MD, MS; Christopher Graber, MD, MPH, FIDSA; Karl Madaras-Kelly, PharmD, M.P.H.; Matthew Samore, MD, FSHEA; Charlene Weir, PhD

1075

Changing Pattern of Antibiotics Usage Among Hospitalized Patients of a Tertiary Hospital in South Korea: 2004-2013
Bongyoung Kim, M.D. Ph.D.; Hyeonjun Hwang, M.S.; Myoung-Jae Lee, Ph.D; Jieun Kim, M.D, Ph.D; Hyunjoo Pai, M.D. Ph.D.

Posters

HYU_Abt_changing pattern_20170831.pdf (691.2 kB)

1076

Effectiveness of Antimicrobial Use and Diagnostic Testing in the Postoperative Setting for Colectomy, Craniectomy and Knee Arthroplasty
Huma Saeed, M.D.; Jennifer Grant, MD; Eric Bhaimia, DO; Ronak Parikh, DO; Frances Lahrman, DO; Moira C. McNulty, MD; Ari Robicsek, MD; Rema Padman, PhD; Nirav Shah, MD, MPH

Posters

Huma_Saeed_-_IDSA_efficiency_poster[1].pdf (1.3 MB)

1077

Using Preventive Health Alerts in the Electronic Health Record Improves Testing Rates for Infants Perinatally-Exposed to Hepatitis C
Leila Hojat, MD; Amrita Bhardwaj, MD; David Bar-Shain, MD; Peter Greco, MD; Nazha Abughali, MD

1078

Use of a Precision Antibiotic Therapy (PAT) Prediction Model to Identify Multidrug-Resistant (MDR) Enterobacteriaceae
Alexandra Varga, PharmD; Leigh Cressman, MA; Ebbing Lautenbach, MD, MPH, MSCE; Valerie Cluzet, MD; Pam Tolomeo, MPH; Warren Bilker, PhD; Keith Hamilton, MD

Posters

VargaA-PAT Prediction Model to identify MDR Enterobacteriaceae.pdf (159.1 kB)

1079

Joint consultation clinic by Infectious Diseases Specialists and Podiatry team (ID-POD) compliments the care of diabetic patients with foot infections by reducing cost and decreasing outpatient clinic visits
Pushpalatha Bangalore Lingegowda, MBBS MD (INFECTIOUS DISEASES); Say-Tat Ooi, MD; Jyoti Somani, MD; Chelsea Law, MSc podiatry; Boon Kiak Yeo, BSc podiatry

Posters

KTPH-DrPushpal-IDSA-FitTo100cmX200cm-v1.pdf (1.3 MB)

1080

Opportunities in the Acute Care Setting for Infectious Diseases/Hospitalist Patient Co-Management
Siddhi Gupta, DO; Amit Bansal, MD; Eric Newman, MD; Stanley Martin, MD

1081

Implementation of a Centralized Infectious Diseases Telehealth (IDt) Service for 16 Small Community Hospitals
Todd J. Vento, MD, MPH; Stephanie S. Gelman, MD; John J. Veillette, PharmD; Mary A. Adams, RN, BSN; Katherine A. Repko, RN, MSN; Peter S. Jones, MSLS; Brandon J. Webb, MD; Kristin K. Dascomb, MD, PhD; Bert K. Lopansri, MD, FIDSA; Edward A. Stenehjem, MD, MSc

Posters

ID Telehealth IDWeek2017_Poster_Vento_20SEP17.pdf (2.3 MB)

1082

Population-Level Hepatitis C Testing Using A Personal Electronic Health Portal System Significantly Improves Screening Rates in Baby Boomers
Leila Hojat, MD; David Kaelber, MD, PhD, MPH; Ann Avery, MD

1083

2015-2016, Georgia Department of Public Health Districts, Evaluating Oral Health Services in Ryan White Part B Clinics
Elizabeth Rabold, MD; Gregory Felzien, MD, AAHIVS; Michael Coker, MSN, RN, ACRN

1084

Comparison of Outcomes in Outpatient Parenteral Antimicrobial Therapy (OPAT) Patients Receiving Vancomycin versus Non-Vancomycin Anti-MRSA Therapy
Carolyn Stoneking, Pharm.D.; Ryan P. Moenster, Pharm.D., FIDSA; Travis W. Linneman, Pharm.D.

Posters

Vanco vs NVAMT IDWeek 2017 Poster 09202017.pdf (233.3 kB)

1085

Potentially Inappropriate Durations of Anti-Infective Therapy at Hospital Discharge Despite Inpatient Antimicrobial Stewardship
Neal Fox, BSPS; Lauren Haines, BSPS; Rachel Bull, BSPS; Zachary Jenkins, PharmD, BCPS; John Ballentine, PharmD; Steven Burdette, MD, FIDSA; Craig Pleiman, PharmD

Posters

ID Week Poster.pdf (803.9 kB)

1086

Patient Self-Referral to Infectious Diseases Clinic: You Don’t Always Get What You Want, But Hopefully What You Need
Katherine Holman, MD; Eric Wolske, BA; Demeatrice Nance, .; Jeff Olender, MBA; Kristin Englund, MD; Steven Gordon, MD

1087

Outpatient Parenteral Antimicrobial Therapy (OPAT) Practices at a Veterans Affairs Hospital: Potential for Pharmacist Impact
Catherine Yang, Pharm.D.; Nancy N. Nguyen, Pharm.D., BCPS, AAHIVP, FCSHP; Aarthi Chary, MD; Trisha S. Nakasone, Pharm.D., BCPS AQ-ID

Posters

Poster 1087.pdf (441.9 kB)

1088

Safety and Effectiveness of Outpatient Parenteral Antimicrobial Therapy (OPAT) in the Aged Population
Lucinda J. Van Anglen, PharmD; Richard M. Mandel, MD, FIDSA; Ramesh V. Nathan, MD, FIDSA; Andrew H. Krinsky, MD; Quyen Luu, MD; Alfred E. Bacon, Iii, MD; H. Barry Baker, MD, FACP; Claudia P. Schroeder, PharmD, PhD; Kimberly A. Couch, PharmD, MA, FIDSA, FASHP

Posters

IDWeek 2017_Van Anglen et al_1088_OPAT in the Aged.pdf (378.3 kB)

1089

Emergency Department Utilization during Self-Administered Outpatient Parenteral Antimicrobial Therapy
Anisha Ganguly, B.S., B.A.; Larry Brown, MS, MPH; Deepak Agrawal, MD, MPH; Kavita Bhavan, MD, MHS

1090

Early ID Outpatient Follow-up of OPAT Patients Reduces 30-day Readmission
Ena Saini, MD; Mohammad Ali, MD, MPH; Ping Du, MD, PhD; Tonya Crook, MD; John Zurlo, MD

1091

Follow-up Appointment Adherence of Outpatient Parenteral Antimicrobial Therapy (OPAT) Patients
Ambika Lall, BA; Angela Hu, MD; Geneve Allison, MD, MSc

Posters

ID Week OPAT Poster Final(2).pdf (200.0 kB)

1092

Pilot of a Home Telehealth Platform in a Pediatric OPAT Program
Louise Vaz, MD, MPH; Tamara Wagner, MD; Bryan Cochran, BA*; Mark Lovgren, MBA

1093

Utilizing a Post-discharge Telephone Call in Outpatient Parenteral Antimicrobial Therapy (OPAT): Findings from a Quality Improvement Project
Kimberly Felder, PA-C, MCR; Louise Vaz, MD, MPH; Penelope Barnes, MBBS, MRCP, FRCPATH, PhD; Cara Varley, MD, MPH

Posters

9_19_17 Felder IDSA Poster.pdf (367.5 kB)

1094

Emergency Department Visits during Outpatient Parenteral Antimicrobial Therapy: A Cohort Study
So Lim Kim, BA; Angela Everett, AAS; Susan J. Rehm, MD, FIDSA; Steven Gordon, MD; Nabin Shrestha, MD, MPH, FIDSA, FSHEA

Posters

opat_ed_poster.pdf (495.8 kB)

1095

Outpatient Parenteral Antibiotic Therapy (OPAT) Serial Readmissions and High Utilizers: Drilling Down on Readmission Following Discharge on Intravenous Antibiotics
Mary-Margaret Andrews, MD; Megan Gallagher, MD; Mary Gentry, MHSA

Posters

OPAT serial readmitters and high utilizers.pdf (333.1 kB)

1096

Risk Factors for Readmission in Patients with Outpatient Parenteral Antimicrobial Therapy
Victoria Huang, PharmD; Polina Lerner, PharmD, BCPS; Jorg Ruhe, MD, MPH; Marianna Fedorenko, PharmD, BCPS

Posters

Risk Factors for Readmission in Patients Discharged with OPAT Poster IDWeek 2017.pdf (1.2 MB)

1097

Impact of an Antimicrobial Stewardship Program Led OPAT Program on Clinical Complications and Frequency of Hospital Readmissions
J. Andrew Carr, Pharm.D., BCPS (AQ-ID); John W. Baddley, MD; Sonya Heath, MD; Rachael A. Lee, MD; Todd P McCarty, MD

Posters

IDWeek 2017.Poster.Final.pdf (478.0 kB)

1098

Characterization of Readmissions Among Patients Enrolled in an Outpatient Parenteral Antimicrobial Therapy (OPAT) Program Over a Two-Year Period at UNC Medical Center
Onyeka Nwankwo, MD; Anh Eichholz, PA-C; Vahini Chundi, MD; Alan Kinlaw, PhD; Tenesha Medlin, RN; Lisa Fletcher, PharmD; Wesley Kufel, PharmD; Claire Farel, MD, MPH; Ashley Marx, PharmD

Posters

Readmissions ID Week 10 2 FINAL.pdf (280.9 kB)

1099

Predictive clinical rule for readmissions in OPAT. Improving in security
Itsaso Bengoetxea, MD; Miren J. Onaindia, MD; Antonio Apezetxea, PhD; Montserrat Gomez, MD; Muskilda Goyeneche, MD; Magdalena Fernandez, MD; Begoña Vazquez, MD; Miriam Berroete, MD; Itziar Olarreaga, MD; Jose M. Quintana, MD, PhD; Urko Aguirre, BSST

Posters

sandiego1099.pdf (660.9 kB)

1100

Stability of Anidulafungin in Concentrated Pharmaceutical Solution
Chien Yap, B.Sc.(Pharm)(Hons); Chi Lui Ho, B.Pharm.(Hons), PhD.; Yin Shan Lim, B.Sc.(Pharm)(Hons).BCNSP; Siang Fei Yeoh, B.Pharm(Hons), M.Pharm, BCPS(Aq-ID) AP(Infectious Diseases)

Posters

FYP Poster CAA 03032017.pdf (661.3 kB)

1101

Impact of obesity on acute kidney injury incidence among patients treated with piperacillin-tazobactam and vancomycin
W. Cliff Rutter, PharmD, MS; Ronald Hall, PharmD, MSCS; David S. Burgess, PharmD, FCCP, FIDP

1102

Incidence of acute kidney injury among intensive care unit patients receiving vancomycin in combination with cefepime or piperacillin-tazobactam
W. Cliff Rutter, PharmD, MS; David S. Burgess, PharmD, FCCP, FIDP

1103

A Little Bit of Dalba Goes a Long Way: Dalbavancin Use in a Vulnerable Patient Population
Chloe Bryson-Cahn, MD; Alison Beieler, PA-C, MS; Jeannie Chan, PharmD, MPH; Steve Senter, BS; Robert Harrington, MD; Shireesha Dhanireddy, MD

Posters

Dalba IDWEEK Poster FINAL.pdf (536.9 kB)

1104

Safety and Efficacy of Telavancin at an Outpatient Parenteral Antibiotic Therapy (OPAT) Unit in New York City
George D. Rodriguez, Pharm.D.; Lorena Polo, M.D.; Carl Urban, PhD; Glenn Turett, MD; Nishant Prasad, MD; Nathan Warren, P.A.-C.; Demetra Tsapepas, PharmD, BCPS; Rabindra Ghimire, M.D.; Sorana Segal-Maurer, M.D.

Posters

Rodriguez_Telavancin_IDWeek 1104.pdf (609.7 kB)

1105

To Add or Not to Add: Would the Addition of Dalbavancin to Formulary Decrease Admissions for Acute Bacterial Skin and Skin Structure Infections (ABSSSI)?
Dustin Freshwater, PharmD; Nina Murphy, PharmD; Michelle T. Hecker, MD

1106

Is there a significant difference in acute kidney injury incidence among patients treated with vancomycin combined with cefepime or meropenem?
W. Cliff Rutter, PharmD, MS; David S. Burgess, PharmD, FCCP, FIDP

1107

Pharmacist-Directed Use of Dalbavancin in Acute Bacterial Skin and Skin Structure Infections to Reduce Hospital Length of Stay
Bruce Jones, PharmD, BCPS; Roby Hersey, PharmD; Joseph Crosby, PhD, RPh; Christopher Bland, PharmD, BCPS, FIDSA

Posters

Dalbavancin ID Week Poster PDF.pdf (563.5 kB)

1108

Experience with High Dose Once-daily Vancomycin for Patients with Skin and Soft Tissue Infections in an Ambulatory Setting
Maggie Wong, PharmD; Michael G. Chapman, MD; Sangita Malhotra, MD; Yazdan Mirzanejad, MD; Gregory D. Deans, MD, MHSc

Posters

IDWeek Poster FINAL.pdf (410.0 kB)

1109

Using Group-Based Trajectory Temperature Modeling to Predict Postoperative Infections after Total Knee Arthroplasty
Jennifer Grant, MD; Moira C. Mcnulty, MD; Krista Kinnard, MS; Daniel Nagin, PhD; Ari Robicsek, MD; Ravi Bashyal, MD; Rema Padman, PhD; Nirav Shah, MD, MPH

Posters

JGrant_GBTM&TKA_IDWeek.pdf (2.6 MB)

1110

Weighing in: Effect of BMI on postoperative fever and complications in patients undergoing three distinct surgeries
Eric Bhaimia, D.O.; Moira C. McNulty, MD; Frances Lahrman, DO; Ronak Parikh, DO; Huma Saeed, M.D.; Ari Robicsek, MD; Rema Padman, PhD; Nirav Shah, MD, MPH; Jennifer Grant, MD

Posters

Eric Bhaimia - IDSA BMI poster_Final.pdf (501.6 kB)

1111

Current Use of Intravenous (IV) Long Acting Antibiotic (LAA) Therapy in the Aetna Health Plan among Patients with Acute Bacterial Skin and Skin Structure Infection (ABSSSI)
Rajesh Mehta, RPh, MS; Alison Edwards, MStat; Katelyn R. Keyloun, PharmD, MS; Nicole Bonine, PhD, MPH; Iver Juster, MD

Posters

Healthagen(DAL17075.5313).pdf (347.9 kB)

1112

Peripherally Inserted Central Catheter Complications in Rural vs. Uban Children Receiving Long-Term Parenteral Antimicrobial Therapy
Natasha Beachum, BS; Walter Dehority, MD, MSc

1113

Injection Drug Use and Infectious Disease Practice: A National Provider Survey
Alison B. Rapoport, MD; Susan E. Beekmann, RN, MPH; Philip M. Polgreen, MD; Christopher F. Rowley, MD/MPH

Posters

RAPOPORT EIN ID WEEK POSTER 2017.pdf (536.0 kB)

1114

Implementation of a Standardized Protocol for Hospitalized Patients Who Inject Drugs and Require Long-Term Antibiotics Reduces Length of Stay Without Increasing 30-Day Readmissions
Robert J. Rolfe Jr., MD; Ronnie E. Mathews, MD; J Martin Rodriguez, MD; Cayce S. Paddock, MD; Peter S. Lane, DO; Benjamin B. Taylor, MD; Rachael A. Lee, MD

Posters

IVATPoster.pdf (859.8 kB)

1115

Systematic Review of Professional Liability when Prescribing Beta-Lactams for Patients with a Known Penicillin Allergy
Meghan Jeffres, PharmD; Elizabeth Hall-Lipsy, JD, MPH; S. Travis King, PharmD, BCPS; John Cleary, PharmD

Posters

PCN case review - ID Week poster 2017.pdf (91.9 kB)

1116

Adverse Drug Reactions Among Patients Enrolled in an Outpatient Parenteral Antimicrobial Therapy (OPAT) Program 2015-2016 at UNC Medical Center
Vahini Chundi, MD; Anh Eichholz, PA-C; Onyeka Nwankwo, MD; Alan Kinlaw, PhD; Wesley Kufel, PharmD; Tenesha Medlin, RN; Lisa Fletcher, PharmD; Ashley Marx, PharmD; Claire Farel, MD, MPH

Posters

UNC OPAT ADR POSTER 1116.pdf (320.2 kB)

1117

Variation in Reporting of Penicillin Allergy and its Consequences : an Evaluation of 13 Hospitals
Florian Daragjati, PharmD, BCPS; David Silver, PharmD, BCPS; Roy Guharoy, PharmD, MBA; Clariecia Groves, MS; Danielle Sebastian, PharmD, BCPS; Mohamad Fakih, MD, MPH

Posters

Penicillin Poster-V4.pdf (205.2 kB)

1118

Adverse Events Releated to Antibiotic Use in Patients with Myasthenia Gravis
Kristen Zeitler, PharmD; Ripal Jariwala, PharmD; Jose Montero, MD, FACP, FIDSA

Posters

ID Week Poster TGH 2017 - MG FINAL.pdf (362.9 kB)

Navigation

Browse by Day:

Browse by Track: